PT-141

PT-141 — THE DESIRE PEPTIDE 🔥

PT-141, also known as Bremelanotide, is a peptide that stands out because it works differently from traditional sexual-performance medications. Rather than primarily targeting blood flow, it acts on melanocortin receptors in the brain, pathways involved in sexual desire and arousal.

🔥 What does it target?
• Sexual desire and arousal pathways
• Melanocortin receptors in the brain
• Libido-related signalling

PT-141 has been researched in both men and women. In the United States, bremelanotide is FDA-approved under the name Vyleesi for a specific condition—acquired, generalized hypoactive sexual desire disorder (HSDD) in certain premenopausal women. It is not FDA-approved as a general libido or erectile-dysfunction treatment for men.

Think of PT-141 as targeting the brain’s desire signals rather than simply targeting blood flow

For Research Purposes only.